The 64 references in paper O. Kuzmin B., Vladislav Zhezha V., Vitaly Belyanin V., Larisa Landar N., Олег Кузьмин Борисович, Владислав Жежа Викторович, Виталий Белянин Васильевич, Лариса Ландарь Николаевна (2016) “Гломерулярная гипертензия: молекулярные механизмы повреждения подоцитов и мезангиальных клеток // Glomerular hypertension: molecular mechanisms of podocytes and mesangial cells damage” / spz:neicon:nefr:y:2016:i:4:p:31-39

1
Palatini P, Dorigatti F, Saladini F et al. Factors associated with glomerular hyperfiltration in the early stage of hypertension. Am J Hypertens 2012; 25 (9): 1011-1016
(check this in PDF content)
2
Hills GS, Heudes D, Jacguort C et al. Morphometric evidence for impaired of renal autoregulation in advanced essential hypertension. Kidney Int 2006; 69 (5): 823-831
(check this in PDF content)
3
Helal I, Fick-Brosnohan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration, definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012; 8 (5): 293-300
(check this in PDF content)
4
Сalstrom M, Wilcox CS, Arendshorst WJ. Renal autoregulation in health and disease. Physiol Rev 2015; 95 (2): 405-511
(check this in PDF content)
5
Loutzenhiser R, Griffin K, Willianson J, Bidani A. Renal autoregulation: new perspectives regarding the prospective and regulatory roles of the underlying mechanisms. Am J Physiol Regul 2006; 290 (5): R1153-R1167
(check this in PDF content)
6
Friedrich C, Endlich N, Kriz W, Endlich K. Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Renal Physiol 2006; 291 (4): F856-F865
(check this in PDF content)
7
Wang G, Lai F, Ching-Ha Kwan et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009; 22 (3): 300-306
(check this in PDF content)
8
Ruster C, Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 2011; 22 (7): 1189-1199
(check this in PDF content)
9
Navar LG. Intrarenal renin-angiotensin system in regulation of glomerular function. Curr Opin Nephrol Hypertens 2014;23 (1): 38-45
(check this in PDF content)
10
Velez JC, Ierardi JL, Bland AM et al. Enzymatic processing of angiotensin peptides by human glomerular endothelial cells. Am J Physiol Renal Physiol 2012; 302 (12): F1583-F1594
(check this in PDF content)
11
Velez JC, Bland AM, Arthur JM et al. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007; 293 (2): F398-F407
(check this in PDF content)
12
Кузьмин ОБ, Бучнева НВ, Пугаева МО. Почечные гемодинамические механизмы формирования гипертонической нефропатии. Нефрология 2009; 13 (4): 28-36 [Kuz’min OB, Buchneva NV, Pugaeva MO. Pochechnye gemodinamicheskie mechanizmy formirovaniya gipertonichezkoj nefropatii. Nefrologiya 2009; 13 (4): 28-36]
(check this in PDF content)
13
Liebau MC, Lang D, Bohm J et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006; 290 (3): F710-F719
(check this in PDF content)
14
Harrison-Bernard L, Chappell MC. Introveling the glomerular RAS: one peptidase at a time. Am J Physiol Renal Physiol 2012; 303 (3): F373-F374
(check this in PDF content)
15
Silveira KD, Pompermauer KS, Lucio RL et al. ACE 2-angiotensin-(1-7)-Mas axis in renal ischemia/reperfusion injury in rats. Clinical Science 2010; 119 (9): 385-394
(check this in PDF content)
16
Durvasula RV, Petermann AT, Hiromura K et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65 (1): 30-39
(check this in PDF content)
17
Durvasula RV, Shankland SJ. The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep 2006; 8 (2): 132-138
(check this in PDF content)
18
Obata J, Nakamura T, Takano H et al. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000; 18 (9): 1247-1255
(check this in PDF content)
19
Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39 (2): 316-322
(check this in PDF content)
20
Hsu HH, Hoffmann S, Endlich N et al. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J Mol Med (Berl) 2008; 86 (12): 1379-1394
(check this in PDF content)
21
Miceli I, Burt D, Tarabra E et al. Stretch reduces nephrin expression via an angiotensin II-AT(I)-dependent mechanism in human podocytes: effect of rosiglitazone. Am J Physiol Renal Physiol 2010; 298 (2): F381-F390
(check this in PDF content)
22
Kriz W, Lemley KV. A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 2015; 26 (2): 258-269
(check this in PDF content)
23
Li Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008; 172 (2): 299-308
(check this in PDF content)
24
Chen X, Ren Z, Liang W et al. C-Abl mediates angiotensin II-induced apoptosis in podocytes. J Mol Histol 2013; 44 (5): 597-608
(check this in PDF content)
25
Zhang C, Xia M, Boini KM et al. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia. Pflugers Arch 2011; 462 (3): 455-467.
(check this in PDF content)
26
Chen S, Meng XF, Zhang C. Role of NADPH oxidasemediated reactive oxygen species in podocyte injury. Biomed Res Int 2013; 839761
(check this in PDF content)
27
Abais JM, Zhang C, Xia M et al. NADPH oxidase-mediated triggering of inflammasone activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid Redox Signal 2013; 18 (13): 1537-1548
(check this in PDF content)
28
Liy Y, Hitomi H, Diah S et al. Roles of Na+/H+ exchanger type 1 and intracellular pH in angiotensin II-induced reactive oxygen species generation and podocyte apoptosis. J Pharmacol Sci 2013; 122 (3): 176-183
(check this in PDF content)
29
Dessapt C, Baradez MO, Hayward A et al. Mechanical forces and TGF-β1 reduce podocytes adhesion through alpha3beta1 down regulation. Nephrol Dial Transplant 2009; 24 (9): 2645-2655
(check this in PDF content)
30
Riser BL, Cortes P, Yee J. Modelling the effects of vascular stress in mesangial cells. Curr Opin Nephrol Hypertens 2000; 9 (1): 43-47
(check this in PDF content)
31
Chen G, Chen X, Sukumar A et al. TGF-β receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells. J Cell Sci 2013; 126 (Pt 16): 3697-3712
(check this in PDF content)
32
Zheng B, Peng F, Wu D et al. Caveolin-1 phosphorilation is required for stretch-induced EGFR and Ekt activation in mesangial cells. Cell Signal 2007; 19 (8): 1690-1700
(check this in PDF content)
33
Giunti S, Pinach S, Arnoldi L et al. The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells. Kidney Int 2006; 69 (5): 856-863
(check this in PDF content)
34
Kang YS, Li Y, Dai C et al. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 2010; 78 (4): 363-373
(check this in PDF content)
35
Wang D, Dai C, Li Y, Liu Y. Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria. Kidney Int 2011; 80 (11): 1159-1169
(check this in PDF content)
36
Das R, Xu S, Quan X et al. Upregulation of mitochondrial Nox4 mediates TGF-β-induced apoptosis in cultured mouse podocytes. Am J Physiol Renal Physiol 2014; 306 (2): F155-F167
(check this in PDF content)
37
Yao M, Wang X, Zhong T et al. The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes. Int J Mol Med 2015; 36 (1): 294-300
(check this in PDF content)
38
Zhou Y, Poczatek MH, Berecek KH, Murphy-Ullrich JE. Trombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun 2006; 339 (2): 633-641
(check this in PDF content)
39
Lee HS. Mechanisms and consequences of TGF-β overexpression in podocytes in progressive podocyte disease. Cell Tissue Res 2012; 347 (1): 129-140
(check this in PDF content)
40
Jiang F, Liu GS, Dusting GJ, Chan EC. NADPH oxidase-dependent redox signaling in the TGF-β-mediated fibrotic responses. Redox Biol 2014; 2: 267-272
(check this in PDF content)
41
Галишон П, Гертиг А. Эпителиально-мезенхимальная трансформация как биомаркер почечного фиброза: готовы ли мы применить теоретические знания на практике? Нефрология 2013; 17 (4): 9-16. [Galishon P, Gertig A. Jepitelialnomezenchimalnaya transformaciya kak biomarker pochechnogo fibroza: gotovy li my primenit teoreticheskie znanija na praktike. Nefrologia 2013; 17 (4): 9-16]
(check this in PDF content)
42
Kim MK, Maeng YI, Sung WJ et al. The differential expression of TGF-β1, ILK and Wnt signaling including epithelial to mesenchymal transition in human renal fibrogenesis: an immunohistochemical study. Int J Clin Exp Pathol 2013; 6 (9): 1747-1758
(check this in PDF content)
43
Lamouille S, Jian X, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15 (3): 178-196
(check this in PDF content)
44
Liu Y. New insights into epithelial- mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21 (2): 212-222
(check this in PDF content)
45
Herman-Edelstein M, Thomas MC, Thallas-Bonke V et al. Differentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy. Diabetes 2011; 60 (6): 1779-1788
(check this in PDF content)
46
Ito Y, Aten J, Nquyen TQ et al. Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol 2011; 117 (1): e9-20
(check this in PDF content)
47
Huang HC, Liang Y, Cheng LG. Transforming growth factor beta 1 modulates connective tissue growth factor expression via Smad 2 signaling pathway in podocyte in vitro. Zhonqhua Yi Hue Za Zhi 2004; 84 (7): 574-577
(check this in PDF content)
48
Fuchshofer R, Ullmann S, Zeilbeck LF et al. Connective tissue growth factor modulates actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury. Histochem Cell Biol 2011; 136 (3): 301-319
(check this in PDF content)
49
May CJ, Saleem M, Welsh GI. Podocyte dedifferentiation: a specialized process for a specialized cell. Front Endocrinol (Lausanne) 2014; 5: 148
(check this in PDF content)
50
Wang G, Lai FM, Kwan BC et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009; 22 (3): 300-306
(check this in PDF content)
51
Chen X, Ren Z, Liang W et al. c-Abl mediates angiotensin IIinduced apoptosis in podocytes. J Mol Histol 2013; 44 (5): 597-608
(check this in PDF content)
52
Liu Y, Liang W, Yang Q et al. IQGAP1 mediates angiotensin II-induced apoptosis of podocytes via ERK ½ signaling pathway. Am J Nephrol 2013; 38 (5): 430-444
(check this in PDF content)
53
Das R, Xu S, Qwan X et al. Upregulation of mitochondrial Nox 4 mediates TGF-β-induced apoptosis in cultured mouse podocytes. Am J Physiol Renal Physiol 2014; 306 (2): F155-F167
(check this in PDF content)
54
Das R, Xu S, Nguyen TT et al. Transforming growth factor-β1-induced apoptosis in podocytes via extracellular-signalregulated kinase – mammalian target of Rapamycin complex 1-NADPHoxidase 4 axis. J Biol Chem 2015; 290 (52): 30830-30842
(check this in PDF content)
55
Schiffer M, Mundel P, Shaw AS et al. A novel role for the adaptor molecule CD2-associated protein in transforming growth factorβ-induced apoptosis. J Biol Chem 2004; 279 (35): 37004-37012
(check this in PDF content)
56
Wu DT, Bitzer V, Ju W et al. TGF-β concentration specifies differential signaling profiles of growth/arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol 2005; 16 (11): 3211-3221
(check this in PDF content)
57
Becker BN, Yasuda T, Kondo S et al. Mechanical stretch/ relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Exp Nephrol 1998; 6 (1): 57-66
(check this in PDF content)
58
Gorin Y, Ricono JM, Wagner B et al. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J 2004; 381 (Pt 1): 231-239
(check this in PDF content)
59
Block K, Ricono JM, Lee DY et al. Arachidonic aciddependent activation of a p22(phox)-based NADPH oxidasemediates angiotensin II-induced mesangial protein synthesis and fibronectin expression via Akt/PKB. Antioxid Redox Signal 2006; 8 (9-10): 1497-1508
(check this in PDF content)
60
Zhang F, Sun D, Chen J et al. Simvastatin attenuates angiotensin II-induced inflammation and oxidative stress in human mesangial cells. Mol Med Rep 2015; 11 (2): 1246-1251
(check this in PDF content)
61
Ding K, Wang Y, Jang W et al. Qian-Yang Yu Jin Granulecontaining serum inhibits angiotensin II-induced proliferation, reactive oxygen species production and inflammation in human mesangial cells via an NADPH oxidase 4-dependent pathway. BMC Complement Altern Med 2015; 15: 81
(check this in PDF content)
62
Naito T, Masaki T, Nikolic-Paterson DJ et al. Angiotensin II-induced trombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent of TGF-β1. Am J Physiol Renal Physiol 2004; 286 (2): F278-F287
(check this in PDF content)
63
Schnaper HW, Hayashida T, Hubchak ST, Poncelet AC. TGF-β-signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003; 284 (2): F243-F252
(check this in PDF content)
64
Chen G, Wang T, Uttarwar R et al. SREBP-1 is a novel mediator TGF-β1 signaling in mesangial cells. J Mol Cell Biol 2014; 6 (6): 516-530 Сведения об авторах: Проф. Кузьмин Олег Борисович
(check this in PDF content)